Our Pricing

Mounjaro Access: Complete UK Information Guide

Published on: June 03, 2026

Understanding mounjaro access uk online prescription options can feel overwhelming, but the process is straightforward when you know where to look. At Cured Pharmacy, eligible patients can access genuine UK-licensed Mounjaro (tirzepatide) from £124.99 following a free online consultation with our UK-registered prescribers. This guide covers everything you need to know about accessing Mounjaro in the UK, from eligibility criteria to prescription pathways.

What Is Mounjaro and How Does It Work?

Mounjaro contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities [1]. This dual mechanism sets it apart from single-pathway treatments, working on two hormone systems simultaneously to regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. These results represent some of the most significant weight loss outcomes observed in clinical trials for pharmacological obesity treatment. Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device, with doses typically starting at 2.5mg and gradually titrating upward based on individual response and tolerability.

Mounjaro Access UK: NHS vs Private Prescription Routes

Mounjaro became available in the UK through private prescription in early 2024, following MHRA approval for chronic weight management. NHS access remains extremely limited as of 2025, with NICE guidance restricting availability to specialist weight management services in specific circumstances. Most UK patients seeking Mounjaro will need to pursue private prescription routes through registered online pharmacies or private clinics.

Private access requires a clinical assessment by a UK-registered prescriber to determine eligibility based on your BMI, medical history, and weight management goals. At Cured Pharmacy, this assessment is conducted online, typically takes under three minutes to complete, and incurs no consultation fee. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical processes to ensure compliance with UK pharmaceutical regulations.

Eligibility Criteria for Mounjaro in the UK

To be prescribed Mounjaro in the UK, you typically need a BMI of 30 kg/m² or above, or a BMI of 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Your prescriber will also assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy. Previous attempts at weight management through lifestyle modification are usually expected before pharmacological intervention is considered appropriate.

How to Get Mounjaro Through Cured Pharmacy

Accessing Mounjaro through Cured Pharmacy follows a straightforward four-step process designed to meet all UK regulatory requirements while providing convenience. First, complete our free online medical consultation, which asks detailed questions about your health history, current medications, and weight management goals. Second, a UK-registered prescriber reviews your assessment within 24 hours and determines whether Mounjaro is clinically appropriate for you.

If approved, your prescription is issued electronically and sent directly to our dispensary. Third, our GPhC-registered pharmacy team dispenses your medication using genuine UK-licensed stock, with full cold-chain handling for temperature-sensitive biologics. Finally, your Mounjaro is dispatched via tracked courier in discreet, insulated packaging to maintain the required 2-8°C storage conditions during transit. Most patients receive their medication within 1-3 working days of prescription approval.

Transparent Pricing Before You Start

Unlike many online services that hide costs until after consultation, Cured Pharmacy displays upfront pricing before you begin your assessment. Mounjaro is available from £124.99 with the exact cost determined by your prescribed dose. There are no hidden consultation fees, no subscription lock-ins, and no pressure to commit before knowing the full price. This transparent approach reflects our commitment to honest, patient-centred pharmacy practice.

Mounjaro vs Other Weight Loss Treatments Available in the UK

The UK weight loss medication market includes several MHRA-licensed options, each with distinct mechanisms, efficacy profiles, and administration requirements. Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist that achieved 14.9% average weight loss in the STEP-1 trial [3]. Saxenda (liraglutide) is a daily injectable GLP-1 agonist with approximately 8% average weight loss demonstrated in clinical trials [4].

Oral medications include Orlistat, which blocks approximately 30% of dietary fat absorption and typically produces 5-10% weight loss when combined with calorie restriction. Xenical is the branded version of Orlistat at the prescription-strength 120mg dose. Your prescriber will recommend the most appropriate treatment based on your clinical profile, lifestyle factors, injection preference, and previous treatment responses. Some patients may trial multiple medications before finding the optimal match.

Starting Mounjaro: Dosing Schedule and Titration

Mounjaro follows a structured dose escalation protocol designed to minimise gastrointestinal side effects while optimising therapeutic response. All patients begin with a 2.5mg once-weekly injection for the first four weeks. This starter dose allows your body to adapt to the medication's effects on gastric emptying and appetite regulation. After four weeks, the dose typically increases to 5mg weekly, where it may remain or continue escalating at four-week intervals.

Subsequent dose increases progress through 7.5mg, 10mg, 12.5mg, and finally 15mg as the maximum maintenance dose. Not all patients require the highest dose—your prescriber will determine the optimal maintenance dose based on weight loss response, tolerability, and individual treatment goals [1]. Each dose escalation should only occur after at least four weeks at the current dose, and dose increases may be delayed if you experience persistent side effects. The KwikPen device is colour-coded by dose strength to prevent administration errors.

Injection Technique and Storage Requirements

Mounjaro is administered subcutaneously into the abdomen, thigh, or upper arm using the pre-filled KwikPen. The injection takes approximately 10 seconds and uses a fine 31-gauge needle that most patients find comfortable. Rotate injection sites each week to prevent lipohypertrophy. Unused pens must be stored in a refrigerator at 2-8°C and protected from light. Once in use, a pen may be kept at room temperature (up to 30°C) for up to 21 days, making it practical for travel or daily routines.

Managing Side Effects and When to Seek Medical Advice

Like all GLP-1 receptor agonists, Mounjaro commonly causes gastrointestinal side effects, particularly during dose escalation. Nausea, diarrhoea, decreased appetite, vomiting, constipation, and abdominal discomfort affect approximately 20-40% of patients, though symptoms typically diminish over several weeks as tolerance develops [1]. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these effects.

Rare but serious adverse effects require immediate medical attention. Contact your GP or NHS 111 if you experience severe persistent abdominal pain (which may indicate pancreatitis), visual changes, symptoms of thyroid tumours (neck lump, persistent hoarseness, difficulty swallowing), or signs of severe allergic reaction. Hypoglycaemia is uncommon with Mounjaro monotherapy but can occur if you're taking concurrent diabetes medications. Always inform your prescriber of all medications you're taking, including over-the-counter products and supplements. Our clinical team at Cured Pharmacy remains available throughout your treatment for any concerns or questions.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and is subject to clinical suitability as determined by a registered UK prescriber.